Why the study?
Combined mitral and aortic root pathology presents a common surgical challenge, prompting this comparison of the prognoses of mitral valve repair and mitral valve replacement in patients undergoing aortic root surgery.
Population
231 MVP patients and 209 MVR patients undergoing combined mitral valve and aortic root surgery from 2012 to 2025
Comparison
Mitral valve repair (MVP) vs mitral valve replacement (MVR)
Design
Single-centre retrospective cohort study with propensity score matching and multivariable regression analysis
Follow-up
Median 30.0 months
Answers are grounded in this paper and cite their sources.
Retrospective cohort study reveals lower composite complications with mitral repair versus replacement in aortic root surgery patients, indicating superior surgical outcomes.
Objective Combined mitral and aortic root pathology presents a common surgical challenge. This study aims to compare the prognoses of mitral valve repair (MVP) and mitral valve replacement (MVR) in patients undergoing aortic root surgery.Methods This was a single-centre retrospective cohort study. Patients who underwent both mitral valve surgery and aortic root surgery from 2012 to 2025 were consecutively enrolled. The median follow-up time was 30.0 months. The primary endpoint in this study was a composite of in-hospital death, cardiac reoperation and complications. The secondary endpoints included all-cause mortality, cardiac reoperation before discharge and during follow-up, and follow-up valve-related complications. Propensity score matching and multivariable regression analysis were used to adjust for confounding factors.Results There were 231 patients in the MVP group and 209 patients in the MVR group. The primary endpoint occurred in 8.3% of patients in the MVP group and 15.3% of patients in the MVR group. Before discharge and during follow-up, the MVP group showed all-cause mortality and cardiac reoperation in 13.4% and 5.2% of patients, respectively. In the MVR group, these percentages were 14.0% and 7.8%, correspondingly. Follow-up valve-related complications were noted in 10.3% of patients in the MVP group and 10.1% of patients in the MVR group, respectively. After adjusting for confounding factors, the MVP group had a lower incidence of the primary endpoint compared with the MVR group (relative risk, 0.48; 95% CI 0.22 to 0.96; p=0.045), while there were no significant differences in secondary endpoints between the two groups.Conclusion Combined mitral and aortic root surgery is generally safe and effective, with the MVP group showing superior outcomes in terms of the primary endpoint compared with the MVR group. For patients with well-preserved valve conditions, MVP is also a safe and effective method.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: